Amgen Recalls Heart Failure Medication Due to Manufacturing Issues

Amgen has initiated a Class II recall for nearly one million bottles of its heart failure drug, Corlanor, across various dosages. The recall is prompted by the presence of a foreign substance and manufacturing practice deviations at an Italian facility. While the FDA classifies this as potentially causing temporary or reversible health issues, the probability of serious harm is considered low.